Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics
- PMID: 18214850
- PMCID: PMC2562898
- DOI: 10.1002/mnfr.200700081
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics
Abstract
Concomitant administration of botanical supplements with drugs that are P-glycoprotein (P-gp) substrates may produce clinically significant herb-drug interactions. This study evaluated the effects of St. John's wort and Echinacea on the pharmacokinetics of digoxin, a recognized P-gp substrate. Eighteen healthy volunteers were randomly assigned to receive a standardized St. John's wort (300 mg three times daily) or Echinacea (267 mg three times daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (300 mg twice daily, 7 days) and clarithromycin (500 mg twice daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin 0.25 mg) was administered orally before and after each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), elimination half-life, and maximum serum concentration were used to assess the effects of St. John's wort, Echinacea, rifampin, and clarithromycin on digoxin disposition. St. John's wort and rifampin both produced significant reductions (p < 0.05) in AUC((0-3)), AUC((0-24)), and C(max), while clarithromycin increased these parameters significantly (p < 0.05). Echinacea supplementation did not affect digoxin pharmacokinetics. Clinically significant P-gp-mediated herb-drug interactions are more likely to occur with St. John's wort than with Echinacea.
Figures

Similar articles
-
Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.Drug Metab Dispos. 2007 Feb;35(2):240-5. doi: 10.1124/dmd.106.012708. Epub 2006 Nov 1. Drug Metab Dispos. 2007. PMID: 17079360 Free PMC article. Clinical Trial.
-
Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.Drug Metab Dispos. 2006 Jan;34(1):69-74. doi: 10.1124/dmd.105.006312. Epub 2005 Oct 12. Drug Metab Dispos. 2006. PMID: 16221754 Free PMC article. Clinical Trial.
-
Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.Drug Metab Dispos. 2005 Apr;33(4):547-54. doi: 10.1124/dmd.104.002485. Epub 2005 Jan 7. Drug Metab Dispos. 2005. PMID: 15640377
-
Pharmacokinetic interactions of drugs with St John's wort.J Psychopharmacol. 2004 Jun;18(2):262-76. doi: 10.1177/0269881104042632. J Psychopharmacol. 2004. PMID: 15260917 Review.
-
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. J Pharm Pharmacol. 2019. PMID: 29411879 Review.
Cited by
-
Interaction between methadone and clarithromycin as the suspected cause of an opioid toxidrome.BMJ Case Rep. 2021 May 25;14(5):e240647. doi: 10.1136/bcr-2020-240647. BMJ Case Rep. 2021. PMID: 34035018 Free PMC article.
-
Cardiovascular effects of noncardiovascular drugs.Circulation. 2009 Sep 22;120(12):1123-32. doi: 10.1161/CIRCULATIONAHA.107.728576. Circulation. 2009. PMID: 19770411 Free PMC article. Review. No abstract available.
-
Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects.Pharmacotherapy. 2010 Aug;30(8):797-805. doi: 10.1592/phco.30.8.797. Pharmacotherapy. 2010. PMID: 20653355 Free PMC article.
-
Prediction of drug-ABC-transporter interaction--Recent advances and future challenges.Adv Drug Deliv Rev. 2015 Jun 23;86:17-26. doi: 10.1016/j.addr.2015.03.001. Epub 2015 Mar 11. Adv Drug Deliv Rev. 2015. PMID: 25769815 Free PMC article. Review.
-
Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.Clin Pharmacokinet. 2010 Apr;49(4):223-37. doi: 10.2165/11318000-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214407 Review.
References
-
- Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am. Fam. Phys. 1999;59:1239–1244. - PubMed
-
- Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 2002;32:451–478. - PubMed
-
- Zhou S, Gao Y, Jiang W, Huang M, et al. Interactions of herbs with cytochrome P450. Drug Metab. Rev. 2003;35:35–98. - PubMed
-
- Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 2004;36:57–104. - PubMed
-
- Mills E, Wu P, Johnston BC, Galliacano K. Natural health product-drug interactions: a systematic review of clinical trials. Ther. Drug Monit. 2005;27:549–557. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous